Anti-TIF1γ antibody-positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers

被引：4
|
作者：
Imai, Ryosuke [1 ]
Ikemura, Sumie [2 ]
Jinta, Torahiko [1 ]
机构：
[1] St Lukes Int Hosp, Dept Pulm Med, Thorac Ctr, 9-1 Akashi Cho, Chuo City, Tokyo 1048560, Japan
[2] St Lukes Int Hosp, Dept Dermatol, Tokyo, Japan
来源：
RESPIROLOGY CASE REPORTS | 2021年 / 9卷 / 04期
关键词：
Dermatomyositis; durvalumab; immune checkpoint inhibitor; intravenous immunoglobulin;
D O I：
10.1002/rcr2.736
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
We report a case of anti-transcriptional intermediary factor 1 gamma (TIF1 gamma) antibody-positive dermatomyositis following durvalumab treatment. The patient was successfully treated with pulse steroid therapy, high-dose intravenous immunoglobulin (IVIg), and tacrolimus. Durvalumab may induce dermatomyositis, and early diagnosis and aggressive therapy are crucial to prevent severe dermatomyositis, which is potentially treatable.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
    Kurasawa, Kazuhiro
    Arai, Satoko
    Namiki, Yumeko
    Tanaka, Ayae
    Takamura, Yuta
    Owada, Takayoshi
    Arima, Masafumi
    Maezawa, Reika
    RHEUMATOLOGY, 2018, 57 (12) : 2114 - 2119
  • [22] Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
    Zhang, Suo
    Chen, Yu-Lan
    Liu, Cui-Lian
    Xie, Jing-Yi
    Sun, Bao-Dong
    Liu, Dong-Zhou
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] Anti-transcription Intermediary Factor1γ-antibody-positive Dermatomyositis Complicated by Dysphagia
    Kurushima, Shota
    Horai, Yoshiro
    Umeda, Masataka
    Kawakami, Atsushi
    INTERNAL MEDICINE, 2017, 56 (21) : 2965 - 2966
  • [24] Anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: A case report
    Osaki, Megumu
    Tachikawa, Ryo
    Ohira, Junichiro
    Hara, Shigeo
    Tomii, Keisuke
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (01) : 251 - 255
  • [25] Characteristics of anti-melanoma differentiation associated gene 5 antibody-positive dermatomyositis with thrombotic microangiopathy
    Ushijima, Toshiyuki Shiki
    Komai, Toshihiko
    Izuka, Shinji
    Shoda, Hirofumi
    Fujio, Keishi
    MODERN RHEUMATOLOGY, 2024, 34 (05) : 973 - 977
  • [26] Anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: A case report
    Megumu Osaki
    Ryo Tachikawa
    Junichiro Ohira
    Shigeo Hara
    Keisuke Tomii
    Investigational New Drugs, 2021, 39 : 251 - 255
  • [27] Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis
    Gui, Xianhua
    Ma, Miao
    Ding, Jingjing
    Shi, ShenYun
    Xin, Xiaoyan
    Qiu, Xiaohua
    Zhang, Yingwei
    Qiu, Yuying
    Cao, Min
    Huang, Mei
    Cao, Mengshu
    Dai, Jinghong
    Cai, Hourong
    Xiao, Yonglong
    RHEUMATOLOGY, 2021, 60 (08) : 3913 - 3922
  • [28] Rapidly progressive interstitial lung disease combined with pneumocystis jiroveci pneumonia in a patient with single anti-TIF-1γ antibody positive dermatomyositis in the context of an underlying tumor
    Zhang, Hengzhe
    Yue, Jinfeng
    Hou, Xiaohui
    Lu, Hongjun
    Bikdeli, Arezou
    Guo, Haipeng
    Li, Hao
    Li, Daqing
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [29] Anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis in a patient with silicone breast implants
    Okubo, Reimi
    Hayashi, Shujiro
    Tokoro, Shown
    Igawa, Ken
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2024, 7
  • [30] Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease
    Fujisawa, Tomoyuki
    Hozumi, Hironao
    Yasui, Hideki
    Suzuki, Yuzo
    Karayama, Masato
    Furuhashi, Kazuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Inui, Naoki
    Suda, Takafumi
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (08) : 935 - 942
12345